CLINICAL_TRIALS
trial_result
· 2013-11-25
Clinical Trial Update: Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia [Phase 3]
Summary
Phase 3 trial evaluating acyclovir to prevent herpes simplex virus infection in neutropenic patients has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25